FDA grants de novo authorization to AI-powered Scanly Home OCT device
The FDA granted de novo marketing authorization to Notal Vision for the patient self-operated AI-powered Scanly Home OCT device, according to a press release.
Stay updated with breaking news from Davida Eichenbaum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA granted de novo marketing authorization to Notal Vision for the patient self-operated AI-powered Scanly Home OCT device, according to a press release.
In the PULSAR study, White and Asian participants had similar best corrected visual acuity improvements in the 2 mg aflibercept group.
This week's topics include the importance of the 2024 election, common vision problems, more debate on the stadium project and recreational marijuana.
Here are the best blue-light blocking glasses you can buy in 2022. Our experts are also revealing if they really work.
It's time again to check the pulse — of Florida's health care policy and politics.